Marissa Cumbers New
legislation proposed in a Michigan Senate committee would require
health insurance providers to cover testing for human papillomavirus,
providers would be required to cover the HPV test, which exposes a
virus that is linked to cervical cancer, under a two-bill package
sponsored by state Sen. Martha Scott, D-Highland Park.
are dying before their time because they can’t have this
test,” Scott said.
"name": "Bill seeks more HPV coverage",
Mar. 2, 2010 (Canada NewsWire Group) -- /CNW Telbec/ -- Public health
professionals are for the first time invited to the Public Health
Workshop, a bilingual preconference that will be held July 3 to 4,
2010, at the Palais des congrès de Montréal, as a
complement to the 26th International Papillomavirus Conference. The
initiative, proposed jointly by the Public Health Agency of Canada and
the Institut national de santé publique du
Québec, will highlight the many public health issues
connected with preventing human papillomavirus (HPV) and related
diseases and cancers.
Dr. Marc Steben,
Steering Committee co-chair, elaborates: "The Public Health Workshop
will meet a real need for skills development. We are committed to
making the training as interactive as possible, with a view to
exchanging information and building on the lessons learned, in addition
to the many solutions that have come from HPV-related experiences here
Updated: February 23, 2010 2:39pm An
HPV vaccine that protects women from most varieties of genital warts
and cervical cancer, has been approved for use by boys and men in
vaccine, Gardasil, has been approved for boys and men ages nine through
26, the same age range as its approval in girls and women. In 2007, the
federal government announced $300 million in funding to deliver
— The vaccine manufacturer Merck says Health Canada has
approved Gardasil for the prevention of genital warts caused by HPV
infection in boys and men aged nine to 26.
or human papillomavirus, is the most common sexually transmitted
infection and can also cause anal cancer in men. Gardasil has already
been approved for females aged nine to 26 in Canada to prevent cervical
cancer and genital warts.
vaccine is designed to prevent infection by four of the most common
strains of the virus.
The Coastal Health
District will offer women aged 19-26 the full Human Papillomavirus
vaccine. The treatment was developed to help prevent cervical cancer
caused by HPV.
The vaccine is given
over a course of three doses. All three are required for the vaccine to
be fully effective. The series, which normally cost upwards of $160 per
dose, will only cost an administrative fee of $14. However, the Coastal
Health District has said that they will not turn away those who cannot
pay the fee.
02 March 2010 19:54 By Maya Prabhu March could mark a
turning point in the fight against cervical cancer in Uganda.
In the context of the increasing international availability of a new
vaccine, government officials and NGOs involved in the struggle against
cervical cancer will launch a strategic plan to combat the disease.
International: No Cervical Cancer brings care, training and equipment
to clinics and hospitals in 8 countries, screening and treating poor
women. At the same time,
Mulago Hospital, Makerere University, and the organisation PATH will
begin joint research into new methods of screening for the illness.
Efforts also include a pilot vaccination distribution programme
currently taking place in two districts, which aims to gather
sufficient information to make possible a future national vaccination
strategy. Furthermore, the Uganda Cancer Institute will contribute to
plans for a comprehensive national policy on cancer.
Rate of new infections declined with age, study
THURSDAY, Feb. 18 (HealthDay News) -- As women age, they receive fewer
benefits from frequent screening for human papillomavirus (HPV) and
vaccinations to prevent the virus, new research shows.
While infection with certain types of HPV can lead to cervical cancer,
there is a vaccine that can help protect against many of these HPV
However, this study of Costa Rican women, aged 18 to 97, concluded that
the benefits of HPV vaccination and screening are low among women over
the age of 41. The rate of newly detected cancer-causing HPV infections
declined with age, ranging from 35 percent in women aged 18 to 25 to
13.5 percent in women aged 42 and older.
MONTE CARLO, Monaco, Feb. 18
/PRNewswire-FirstCall/ -- Roche Molecular Systems, Inc. (SIX: RO, ROG;
OTCQX: RHHBY) announced today that preliminary data from its ATHENA
(Addressing THE Need for Advanced HPV Diagnostics) trial support the
importance of screening for human papillomavirus (HPV) genotypes that
put women at highest risk for developing cervical cancer. ATHENA is a
prospective, double-blind, multi-centered, 47,000-patient,
U.S.-registration trial designed to demonstrate the effectiveness of
HPV detection as part of a cervical cancer screening program. Thomas C.
Wright Jr., M.D., of Columbia University presented the preliminary data
on February 18 during the Genotyping session (Scientific Session 2) at
the EUROGIN 2010 congress in Monaco.
"The findings to date
from the ATHENA trial support the growing understanding that certain
HPV genotypes are highly associated with the development of high-grade
cervical intraepithelial neoplasia (CIN grade 2 or higher), a direct
precursor to cervical cancer," said Dr. Wright.
JOHANNESBURG, 18 February 2010
(PlusNews) - Cervical cancer is a leading killer among women living
with HIV, but a low-cost screening programme developed in Zambia is
proving that simple techniques can go a long way in saving lives.
New research presented
this week at the 17th Conference on Retroviruses and Opportunistic
Infections (CROI) in San Francisco has shown that cervical cancer
screening among HIV-positive women prevented one death for every 32
Presented by Dr
Groesbeck Parham of the University of Alabama at Birmingham, the
research originated from a pilot study of about 6,600 HIV-positive
women examined as part of the Cervical Cancer Prevention Programme in
Zambia (CCPPZ), an ongoing low-cost screening project. More than half
the women had abnormal results, and about 20 percent were diagnosed as
having lesions at varying stages from pre-cancerous to advanced cancer.
evaluated two molecular methods of HPV detection and their correlation
with cytological and histological diagnosis in a large sample of Greek
All women with liquid-based cytology performed at a University Hospital
between 2000 and 2003 were included. The Hybrid Capture 2 (HC2) kit and
in house Polymerase Chain Reaction (PCR) were used for HPV DNA
biopsy was performed for women with ASCUS+ cytology, HPV detection, or
abnormal colposcopy. Positive (PLR) and negative (NLR) likelihood
ratios were calculated for cytology and HPV molecular testing for the
prediction of CIN2 and greater histology.
ThisDay Reporter 15th
February 2010 Though
cervical cancer is completely preventable, with screening exams and
treatment, it continues to claim a considerable chunk of women
population throughout the world. Considered the fifth most deadly
cancer in women worldwide, cervical cancer affects about 16 per 100,000
women per year and kills about 9 per 100,000 per year, that is 800
women a day.
remains unfortunate that about 83 per cent of the cases occur in
developing countries, representing 15 per cent of female cancers. In
Tanzania, cervical cancer ranks as the first most frequent cancer among
women between 15 and 44 years of age.
in recent years, India has made tremendous economic progress, there is
one area where it still lags woefully behind. I refer here to the
incidence of cancer of the uterine-cervix or cervical cancer. In fact,
we have the dubious distinction of outstripping any other country when
it comes to the number of cases of this type of cancer (132,000 new
cases are reported every year and around 74,000 women die annually of
(Feb. 15, 2010) — The overall potential benefits of human
papillomavirus (HPV) vaccinations or frequent HPV screenings for women
over the age of 41 are low, concludes a new study published online
February 15 in the Journal of the National Cancer Institute. The study
found that the rate of new infections preventable by vaccination
declines with age. Furthermore, new infections among women at any age
typically do not progress to cervical intraepithelial neoplasia grade 2
(CIN 2) or CIN 3, the precursors for cervical cancer.
study was undertaken because researchers wanted to examine whether
women's age and the duration of carcinogenic HPV infections influenced
subsequent persistence of infection and risk of CIN 2 or worse disease.
and Mail Update Published
on Tuesday, Feb. 09, 2010 7:26PM EST Last
updated on Tuesday, Feb. 09, 2010 7:34PM EST Canadian
women who want to be immunized against HPV, a family of viruses that
causes cervical cancer, now have a choice of two competing vaccines.
number of women under the age of 30 diagnosed with cervical cancer will
fall nearly two thirds by 2025 because they have received the HPV
vaccine, according to a study published this week in the British
Journal of Cancer.
researchers calculated the number of cancers that would be prevented by
the vaccine, assuming 80 percent of girls received all three doses.
Twelve and 13-year-old girls in the U.K. have been offered the vaccine
since 2008, and government figures suggest that 78 percent of them had
received all three doses.
-- February 9, 2010 -- Health Canada has approved a new adjuvanted
(AS04) human papillomavirus (HPV) vaccine (types 16 and 18 [Cervarix])
to protect girls and women aged 10 to 25 years against cervical cancer
and abnormal and precancerous cervical lesions.
Canada, more than 1 woman dies every day from cervical cancer, a
disease that is largely preventable," said Barbara Romanowski, MD,
Division of Infectious Diseases, University of Alberta, Edmonton,
Alberta. "Together with regular Pap tests, Cervarix reduces the risk of
cervical cancer caused by HPV types 16 and 18, by 98%."
another vaccination option for families. First we heard the HPV vaccine
could protect girls from some strains of cervical cancer. Now, the same
vaccine can protect boys from something else. Reporter:
is another vaccination option for families. First we heard the HPV
vaccine could protect girls from some strains of cervical cancer. Now,
the same vaccine can protect boys from something else.
There is another vaccination
option for families. First we heard the HPV vaccine could protect girls
from some strains of cervical cancer. Now, the same vaccine can protect
boys from something else. Reporter: Tracy Madden Email Address:
vaccination option for families. First we heard the HPV vaccine could
protect girls from some strains of cervical cancer. Now, the same
vaccine can protect boys from something else.
Nurse Patty Wilderman
feels so strongly about it, she had her two sons take part in a
clinical trial here in Omaha.
2010-02-18 23:42:54 CST Category: Female Specific Tests by
recent study has found that older women benefit less from frequent
human papillomavirus (HPV) vaccinations and screenings than do younger
women. Additionally, researchers found that new infections in women of
any age rarely progressed to cervical intraepithelial neoplasia grade 2
or 3, which are precursors for cervical cancer.
the 7-year study, researchers from the Proyecto Epidemiologico
Guanacaste in San Jose, Costa Rica screened more than 9,000 women of
varying ages. They found that the rate of new HPV infections declined
with age and that the benefits for vaccination were very low among
women over the age of 41.
aged 34 years or older, the potential benefit of HPV vaccination or
frequent HPV screening to prevent or detect new carcinogenic HPV
infections was low. In addition, new infection in women of any age
rarely progressed to cervical intraepithelial neoplasia grade 2 or 3.
HPV infections are the central cause of cervical cancer, and these
infections often clear in younger women; however, there is less
understanding about these infections in older women, according to
conducted a longitudinal study of 9,466 women in Costa Rica grouped by
age to determine whether women’s age and duration of
carcinogenic HPV infections were linked to infection persistence and
risk for CIN grade 2 or higher. There were 9,094 women in the
"name": "Low benefit for HPV vaccination, screening in older women",
available at little or no cost for women who qualify.
Teresa StepzinskiStory updated at 1:09 AM on Saturday, Feb. 13, 2010
Ga. - Coastal Georgia county health departments are offering the Human
Papillomavirus, HPV, vaccine available at little or no cost to women
who meet criteria including those receiving Medicaid or Medicare.
vaccine, commonly known as Gardasil, has been shown to be a safe and
effective medicine to help prevent cervical cancer.
11, 2010 — The quadrivalent vaccine against human
papillomavirus (HPV) types 6, 11, 16, and 18 (Gardasil, Merck &
Co) results in statistically significant reductions of HPV-associated
genital diseases, such as warts and cervical dysplasia, in young women
who receive it, according to the final analysis of 2 randomized
placebo-controlled efficacy trials.
HPV vaccine also statistically significantly reduces Pap test
abnormalities, procedures such as colposcopy, and definitive cervical
therapy, compared with placebo, report the study authors, led by Nubia
Muñoz, MD, from the National Institute of Cancer, in Bogota,
center began offering the HPV vaccine for males after approval in
Rachel Hatch News reporter
Wednesday, January 27, 2010
University Health Center has recommended the human papillomavirus (HPV)
vaccine for women since the Food and Drug Administration approved it in
2006, but it’s now turning its attention toward males.
December, the health center began allowing men to get the HPV vaccine,
and recently, it has been encouraging more men to schedule appointments
for the shots.
would have liked to make the vaccine available to men much
earlier,” Interim Medical Director Jenny Soyke said.
“The (Centers for Disease Control and Prevention)
didn’t approve the vaccine until December, so now we can give
it to them.”
Canada approved a new human papillomavirus (HPV) vaccine this week and
the New Brunswick Department of Health will study it to see if it
should change over its own supply.
Cervarix, a vaccine from
pharmaceutical company GlaxoSmithKline Inc., has been given the green
light by the federal health department and should be available in
Canada by the end of the month. It is designed to protect against HPV,
a sexually transmitted disease that can lead to cervical cancer.
Cervical cancer vaccination will
be available for girls already in first year and for those entering
secondary school, writes MUIRIS HOUSTON
THE HPV vaccination
programme against cervical cancer is now expected to start in
September, targeting both first and second year girls in its initial
stages, the Health Service Executive’s leading vaccination
expert has indicated.
In a memo sent to Prof
Brendan Drumm and other senior HSE managers and seen by The Irish
Times, Dr Kevin Kelleher, assistant national director of population
health, has recommended the option of vaccinating girls who are now in
first year at secondary school as well as those who will be in first
year by September.
Dr Kelleher said this
option offers some economies of scale and will allow more time to
complete discussions with key stakeholders such as school principals
and management boards.
living with HIV who regularly take antiretroviral (ARV) therapy may be
more likely to clear human papillomavirus (HPV) and cervical lesions
than women who don’t consistently take their meds, according
to a study published in the March 1 issue of The Journal of Infectious
have long known that HPV infection causes cervical lesions, also known
as squamous intraepithelial lesions (SIL), and cervical cancer. It is
also well known that rates of HPV infection, SIL and cervical cancer
are higher in HIV-positive women than in the general population. What
has been less clear is whether ARV therapy can reduce the prevalence of
HPV infection and, with it, the risk of HPV-related diseases.
Findings from a
natural-history study of human papillomavirus (HPV) have led the
investigators to conclude that the "potential benefit" of HPV
vaccination in older women (≥42 years) is "low."
The research team,
led by Ana Cecilia Rodríguez, MD, from the Proyecto
Epidemiológico Guanacaste, Fundación INCIENSA, in
San José, Costa Rica, found that the rate of new HPV
infections declines with age and that new infections usually do not
progress to grade 2 or 3 cervical intraepithelial neoplasia (CIN) in
found that infections at baseline were more likely to persist in older
than in younger women (P < .01 for a comparison of 8 groups).
Furthermore, most of the grade 2 or worse CIN disease that was detected
during follow-up (66 of 85 cases) was associated with infections
already present at baseline.
has been the No. 1 cause of death for Japanese since 1981, accounting
for one-third of Japanese deaths. One's lifestyle is closely related to
the contraction of cancer and one can avoid developing cancer to a
large extent by changing one's lifestyle. Thus education can play an
important role. Since many types of cancer develop slowly over many
years, teaching children about the risk of cancer and the importance of
having a healthy lifestyle will go a long way toward reducing cancer.
A report by
researchers from the Geneva-based International Union Against Cancer
(UICC) says that about 40 percent of cancers can be prevented by
adopting a healthy lifestyle. Every year, Feb. 4 is marked as World
Cancer Day, led by UICC and its member organizations in 86 nations with
the support of the World Health Organization. This year UICC started a
campaign "Cancers can be prevented too." WHO estimates that the number
of global cancer deaths will increase 45 percent from 2007 to 11.5
million by 2030, up from 7.9 million deaths at present.
(Feb. 22, 2010) — A panel of governmental, academic and
non-profit scientists speaking at the annual meeting of the American
Association for the Advancement of Science (AAAS) unveiled research
suggesting that diseases found in dolphins are similar to human
diseases and can provide clues into how human health might be affected
by exposure to contaminated coastal water or seafood. "Dolphins and humans
are both mammals, and their diet includes much of the same seafood that
we consume. Unlike us, however, they are exposed to potential ocean
health threats such as toxic algae or poor water quality 24 hours a
day," said Carolyn Sotka of the NOAA Oceans and Human Health Initiative
and lead organizer of the session. "Our ecological and physiological
similarities make dolphins an important 'sentinel species' to not only
warn us of health risks, but also provide insight into how our health
can benefit from new medical discoveries."
Updated: Tuesday, February 23, 2010 | 7:34 PM ET CBC
a vaccine against human papilloma virus (HPV), has been approved as a
treatment to prevent genital warts in males aged nine to 26 in Canada,
the vaccine's manufacturer said Tuesday.
Canada approved Gardasil to prevent infection caused by human papilloma
virus Types six, 11, 16, and 18 and genital warts caused by HPV types
six and 11.
News ServiceFebruary 24, 2010 3:02 AM Health Canada has
approved the use of a vaccine for boys and young men to protect them
against the human papilloma virus and genital warts, pharmaceutical
company Merck Frosst announced Tuesday.
vaccine, Gardasil, was first approved by Health Canada in July 2006 for
females between ages nine and 26, the same age group targeted for
males. HPV is the most common sexually transmitted infection in Canada.
More than 40,000 new cases are estimated annually.
New research shows startling
statistics on sexually transmitted HPV among young adults. The study, conducted by
a team of experts from McGill University and the University of
Montreal, reveals that a startling 56 percent of young people contract
human papillomavirus (HPV) early in their intimate encounters. Valerie
Huber, executive director of the National Abstinence Education
Association (NAEA), tells OneNewsNow the study needs to be taken
seriously because some women develop a form of cervical cancer and
because the highly touted drug Gardasil® is not a fail-safe
of the sexually active men and women in the United States will get the
human papillomavirus (HPV) sometime in their lifetime. While many
people will never know that they have HPV, the genital warts caused by
the sexually transmitted infection can lead to several forms of cancer,
including cervical, vulvar, vaginal, anal and penile cancer.
Initially approved for girls to help prevent cervical cancer, which
kills 4,000 women in the United States annually, a vaccine developed to
protect against HPV infections is now being recommended for boys age 9
to 18 years old, under new guidelines issued earlier this month by the
American Academy of Pediatrics, the U.S. Centers for Disease Control
and Prevention and the American Academy of Family Physicians.
The three-dose HPV vaccine Gardasil, which is manufactured by Merck,
protects against four strains of the human papillomavirus (HPV),
including two that cause 70 percent of cervical cancer cases.
Cancer: A Preventable Disease Hello
willing to bet that very few of you know that January is Cervical
Cancer Awareness Month! I know I didn't. This changed when I was kindly
invited to interview two local experts in the diagnosis and treatment
of this disorder, as well as a patient that actually has it. What
follows is the first in a series of articles focusing on cervical
cancer from both a medical and patient perspective.
Cancer and HPV
human papilloma virus (HPV) has recently been shown to be the most
important risk factor for cervical cancer (a risk factor is something
that increases one's risk of getting a particular disorder). There are
other risk factors such as smoking, immunosuppression (reduced immune
function), multiple full-term pregnancies, oral contraceptive use, and
others; however, these are beyond the scope of the present article,
whose purpose is to focus on the single most important risk factor, the
HPV virus is virtually ubiquitous in the population; if you have ever
had unprotected sex, then the chances are great that you have had (or
currently do have) the virus. The good news is that most peoples'
immune systems manage to clear the virus from their bodies naturally.
However, in some individuals this does not occur, and the virus
persists. In some of those instances, cervical cancer may develop.
Nicolette Pawlowski Tuesday,
February 9, 2010 10:46 p.m.
girlfriend just came back from the doctor. She says she has HPV and
that I probably gave it to her (I was her first). I don’t
have any symptoms. How do I check if I have HPV? Her doctor also told
her to call other people I’ve slept with to get checked out
as well. How the heck do I go about doing THAT?
a Crappy Situation
"name": "Don’t let HPV put damper on sex life",
Feb 12, 2010 12:50 PM Updated:
Feb 15, 2010 2:33 PM
COUNTY, GA (WTOC) - The Human Papillomavirus (HPV) causes cervical
cancer and is found in 8 out of 10 women.
vaccine, Gardasil, is normally $160 per dose; however, the Coastal
Health District will be offering the vaccine free of charge to
non-pregnant women between 19 and 26 years of age through September of
"name": "Free HPV vaccine available",
of the cervix, the lower part of the uterus that connects the womb and
the vagina, is the most common cancer affecting women in India. Nearly
200 women die everyday due to cervical cancer in the country.
Worldwide, cervical cancer accounts for 15 per cent of all cancers in
women, 80 per cent of these occurring in developing countries.
the past, as a medical student, I remember that we saw at least one
patient suffering from cervical cancer per outpatient day in a
government hospital, usually with the cancer having spread so much that
we could not really help her. But today, with Pap Smears being
routinely done we hardly see any invasive cancers. A Pap test or Pap
Smear is a simple test by which we take a smear from the cervix and
look at it microscopically for abnormal cells.
With cancers of the breast and cervical most prevalent ones among women
living in cities, doctors say there is a dire need to spread awareness
about them on a war footing, especially since these are preventable.
This comes soon after experts recommended that cancers should be
notified as this would enable the authorities to get a true picture of
people to come forward for screening, the president of obstetrics and
gynaecology society, Veena Jain, said women's cancers could be
prevented. Jain said the society had decided to work on the theme
— cancer can be prevented too — adding, of all
cancers, the gynaecological ones could be prevented and cured.
cancer is the second most common malignancy among women worldwide, with
about 500,000 cases a year. In developing countries it is the main
cause of cancer deaths in women, and around 250,000 women die each year
because of it. In the United States , cervical cancer strikes about
10,000 women a year and causes nearly 4,000 deaths. This steep rise in
number of cervical cancer cases has led to governments promoting
cervical cancer jabs in an attempt to prevent the spread of this
cancer. In UK alone, more than a million girls are being offered the
jab to protect them from the cancer-causing virus.
cancer has been named as the leading form of cancer in women in Africa
followed by breast cancer, killing one woman every two minutes.
while cervical cancer accounts for 288,000 deaths per year worldwide,
approximately 80 percent of death occurs in developing countries, where
with only weak or non-existent cervical cancer screening and treatment
programmes, it is the leading cause of death in women.
was disclosed by Dr Benjamin Kumbour, the Minister of Health, at the
inauguration of a Local Organising Committee (LOC) on “Stop
Cervical Cancer and Breast Cancer” in Africa Conference to be
hosted in Accra in July.
DELHI: Cervical cancer claims almost half a million women worldwide. In
99.7% of all affected women, it results from a history of persistent
infection by a family of more than 100-related viruses called human
papillomavirus (HPV). As many as 80% of all sexually-active women have
a risk of infection. To address this problem which is the most common
cancer to affect women in India, Times Foundation has organized a
Wellness workshop on the disease in association with Super Religare
Laboratories and Ahlon International School on Friday.
Tierney SmithsonIssue date: 1/29/10 Section: News
January, SRU participates in Cervical Health Awareness Month, an entire
month devoted to providing information on human papilomavirus and
most cases of HPV are seen in ages 18-24, SRU's McClachlan Student
Health Center participates in this event by setting up informational
tables providing insight on cervical health, said Jessica Kaak, peer
educator for Healthy Outreach through Peer Education.
people don't want to talk about cervical cancer. But Appleton's Kellie
Delveaux has made it her life's mission. Delveaux
is co-founder of SAS Cervical Cancer Foundation, founded in memory of
her friend Sybil Ann Seehawer, who was 31 when she died of cervical
cancer in 2008. Delveaux was her caregiver. The
Appleton-based foundation supports women in Wisconsin with daily living
expenses while they are undergoing treatment for cervical cancer,
provides educational resources and raises awareness for women's health
makes it so what happened to (Sybil) wasn't just a tragedy and
forgotten," said Delveaux, one of 40 women chosen to participate last
month in a congressional briefing at the Rayburn House Office Building
on Capitol Hill and a day of lobbying under the auspices of Tamika
& Friends, a Washington D.C.-based nonprofit organization also
dedicated to raising awareness about cervical cancer. "We
just jumped on that bandwagon pretty fast," said Delveaux, who early on
reached out to other cervical cancer foundations such as Tamika
& Friends, run by cervical cancer survivor Tamika Felder, and
Love, Kristen, an Indiana nonprofit run by Kirk and Brenda Forbes, who
lost their 23-year-old daughter, Kristen, to cervical cancer.
UA centers have come together to offer a free public forum about human
papillomavirus and the vaccine.
University Communications January 26, 2010
papillomavirus infections are the most common sexually transmitted
infections in the United States and, to inform the pubilc about the
disease and ways to prevent it, several University of Arizona centers
are sponsoring an education forum.
HPV Educational Forum 2010 is being presented by the Women’s
Studies Advisory Council, Southwest Institute for Research on Women and
the National Center of Excellence in Women’s Health through a
partnership with the Marana Health Center.
bills in the New York State legislature would, if passed, allow
healthcare practitioners to vaccinate children under 18 against HPV
without their parent’s consent. The bills would require the
vaccinations before children could attend school, leading to the
interesting potential scenario of schools vaccinating kids without
their parents’ consent simply because the child wants to stay
Even without the
inevitable controversy over whether under-18s should be able to get
preventive care from their doctors without their parents hearing the
details of their sex lives, the bills read like full-employment acts
for Merck (MRK)’s Gardasil and GlaxoSmithKline
Senate bill No.
“AN ACT to
amend the public health law, in relation to providing medical
care to minors for sexually transmitted diseases without a
parent’s or guardian’s consent.”
cancer starts when cells on the surface of your cervix acquire abnormal
changes and begin to grow out of proportion,forming a mass in your
cervix.THE CERVIX IS THE LOWER PART OF THE WOMB(UTERUS )often called
the neck of the womb and links the womb to the vagina.
cancer is divided into early and advanced stages.In early cervical
cancer the abnormal cells are still confined to the cervix.In advanced
cancer the abnormal cells spread beyond the cervix and may involve the
vagina,uterus,bladder,rectum,lungs and brain.Whilst about 95% of EARLY
CERVICAL CANCER IS CURABLE,ADVANCED CANCER IS NOT AND EVENTUALLY LEADS
Last searchs: hpv, cancer, HPV treatment, oncology, HPV in man, HPV medical center & medical group, www.q es human papilloma virus, benefits of hpv test, hpv dna test men, cervical cancer - human papilloma virus (papovavirus), vin ain cin sin, benefit of hpv screening , vin 1 treatment research, vin 1 treatment research, biology of human papilloma virus, list treatments hpv,